P043 Bevacizumab/paclitaxel as first line therapy for metastatic breast cancer: new schedule in real life
| Autor: | Cannita, K., Paradisi, S., Cocciolone, V., Rinaldi, L., Lanfiuti-Baldi, P., Irelli, A., Cortellini, A., Bruera, G., Ricevuto, E., Ficorella, C. |
|---|---|
| Zdroj: | In The Breast March 2015 24 Supplement 1:S41-S41 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect